drug development, biobusiness

While one company hikes the price of an old drug to treat the parasitic infection, academic researchers report that an approved blood pressure medication could be just what the doctor ordered.

The personal genomics firm announces plans to make medicines.

As medical marijuana businesses set up shop across the U.S., a handful of companies are taking the pharmaceutical route, guiding cannabis-derived drugs through clinical trials.

The $6 billion deal marks yet another massive transaction in the health-care industry.

From San Francisco to St. Louis, biotech incubators are proliferating across North America. Can they deliver on their promise of fueling the economy?
 

Drugmakers are teaming up to test the disease-fighting power of combination therapies earlier in the development cycle than ever before.

Despite chill winds on Wall Street, investors continue to place bets on fledgling biotechnology companies.